BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-01-10 |
|---|---|---|---|---|
| 2025 | $65.92 | $62.87 | $72.65 | -2.16% |
| 2026 | $119.38 | $80.88 | $137.3 | 77.17% |
| 2027 | $138.7 | $116.8 | $146.7 | 105.84% |
| 2028 | $101.11 | $89.68 | $116.09 | 50.06% |
| 2029 | $95.06 | $86.06 | $115.91 | 41.08% |
| 2030 | $90.89 | $78.14 | $102.11 | 34.89% |
| 2031 | $84.0 | $78.16 | $88.59 | 24.67% |
| 2032 | $73.75 | $70.02 | $77.66 | 9.46% |
| 2033 | $66.75 | $61.27 | $76.71 | -0.94% |
| 2034 | $63.0 | $53.52 | $68.35 | -6.51% |
| 2035 | $52.99 | $52.99 | $52.99 | -21.36% |
The 39 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$98.13 with a high forecast of $122.0 and a low forecast of $65.0.
The average BioMarin Pharmaceutical stock forecast represents a 45.64%
increase from the last price of $67.379997253418.
For BioMarin Pharmaceutical stock forecast for 2025, 11 predictions are offered for each month of 2025 with average BioMarin Pharmaceutical stock
forecast of $65.92, a high forecast of $72.65, and a low forecast of $62.87.
The average BioMarin Pharmaceutical stock forecast 2025 represents a -2.16%
decrease from the last price of $67.379997253418.
For BioMarin Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $119.38, a high forecast of $137.3, and a low forecast of $80.88.
The average BioMarin Pharmaceutical stock forecast 2026 represents a 77.17%
increase from the last price of $67.379997253418.
For BioMarin Pharmaceutical stock forecast for 2028, 12 predictions are offered for each month of 2028 with average BioMarin Pharmaceutical stock
forecast of $101.11, a high forecast of $116.09, and a low forecast of $89.68.
The average BioMarin Pharmaceutical stock forecast 2028 represents a 50.06%
increase from the last price of $67.379997253418.
For BioMarin Pharmaceutical stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average BioMarin Pharmaceutical stock
forecast of $90.89, a high forecast of $102.11, and a low forecast of $78.14.
The average BioMarin Pharmaceutical stock forecast 2030 represents a 34.89%
increase from the last price of $67.379997253418.
For BioMarin Pharmaceutical stock forecast 2031, 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $84.0, a high forecast of $88.59, and a low forecast of $78.16.
The average BioMarin Pharmaceutical stock forecast 2031 represents a 24.67%
increase from the last price of $67.379997253418.
For BioMarin Pharmaceutical stock forecast for 2035 (10 year), 1 predictions are offered for each month of 2035 with average BioMarin Pharmaceutical stock
forecast of $52.99, a high forecast of $52.99, and a low forecast of $52.99.
The average BioMarin Pharmaceutical stock forecast 2035 represents a -21.36%
decrease from the last price of $67.379997253418.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $98.13, and this show a -5.41% decrease in average from the prior price target of the each prediction. Also, this average forecast of $98.13 represents a -1.8% decrease from the past average forecast of $99.93, 6 months ago from 14 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-12-12 | Cantor Fitzgerald | $90.00 | $90.0000 | Overweight |
| 2024-11-15 | Wolfe Research | $95.0000 | Outperform | |
| 2024-10-30 | William Blair | Market Perform | ||
| 2024-10-30 | Baird | $72.00 | $65 | Neutral |
| 2024-10-30 | UBS | $104.0000 | $106.0000 | Buy |
| 2024-10-30 | Evercore ISI Group | $115.00 | $105 | Outperform |
| 2024-10-30 | RBC Capital | $80.00 | $80.00 | Sector Perform |
| 2024-10-30 | JP Morgan | $110.0000 | $109.0000 | Overweight |
| 2024-10-30 | Cantor Fitzgerald | $110.00 | $90 | Overweight |
| 2024-10-30 | Canaccord Genuity | $93.00 | $84.0000 | Hold |
| 2024-10-30 | Citigroup | $93.0000 | $81.0000 | Neutral |
| 2024-10-10 | Raymond James | $79.0000 | Outperform | |
| 2024-10-04 | Barclays | $110.00 | $86.0000 | Overweight |
| 2024-10-04 | RBC Capital | $85.00 | $80.0000 | Sector Perform |
| 2024-09-17 | Bernstein | $116.0000 | $90.0000 | Outperform |
| 2024-09-17 | Stifel | $115.00 | $87 | Buy |
| 2024-09-17 | B of A Securities | $130 | $115 | Buy |
| 2024-09-17 | RBC Capital | $100.00 | $85 | Sector Perform |
| 2024-09-17 | Wells Fargo | $115.0000 | $90.0000 | Overweight |
| 2024-09-17 | Truist Securities | $118.00 | $90 | Buy |
| 2024-09-17 | Scotiabank | $95.00 | $78.0000 | Sector Perform |
| 2024-09-13 | Canaccord Genuity | $93.0000 | $93 | Hold |
| 2024-09-09 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
| 2024-09-05 | RBC Capital | $100.00 | $100.00 | Sector Perform |
| 2024-09-05 | Piper Sandler | $107.00 | $122 | Overweight |
| 2024-09-05 | Truist Securities | $140.00 | $118 | Buy |
| 2024-09-05 | Scotiabank | $86.0000 | $95 | Sector Perform |
| 2024-09-05 | JP Morgan | $111.0000 | $120.0000 | Overweight |
| 2024-08-27 | Piper Sandler | $107.00 | $107 | Overweight |
| 2024-08-21 | Stifel | $112.00 | $115 | Buy |
| 2024-08-20 | Bernstein | $94.0000 | $110.0000 | Outperform |
| 2024-08-06 | Evercore ISI Group | $113.0000 | $115 | Outperform |
| 2024-08-06 | Barclays | $111.00 | $110.0000 | Overweight |
| 2024-08-06 | RBC Capital | $100.0000 | $100 | Sector Perform |
| 2024-08-06 | Stifel | $108.0000 | $112 | Buy |
| 2024-08-06 | Scotiabank | $85.00 | $86.0000 | Sector Perform |
| 2024-08-06 | TD Cowen | $125.0000 | $120.0000 | Buy |
| 2024-08-05 | Cantor Fitzgerald | $110.00 | $110.00 | Overweight |
| 2024-07-25 | Canaccord Genuity | $89.00 | $89.0000 | Hold |
| 2024-07-22 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
| 2024-06-27 | Wells Fargo | $110.00 | $115.0000 | Overweight |
| 2024-05-17 | Baird | $104.00 | $72 | Neutral |
| 2024-05-14 | Evercore ISI Group | $113 | Outperform | |
| 2024-04-26 | Canaccord Genuity | $91.00 | $89.0000 | Hold |
| 2024-04-26 | Morgan Stanley | $115.0000 | $112 | Overweight |
| 2024-04-25 | Wells Fargo | $100.0000 | $110.0000 | Overweight |
| 2024-04-25 | Cantor Fitzgerald | $110.0000 | Overweight | |
| 2024-04-25 | Scotiabank | $83.0000 | $85.0000 | Sector Perform |
| 2024-04-25 | Citigroup | $94.0000 | $91.0000 | Neutral |
| 2024-02-29 | Canaccord Genuity | $91.0000 | Hold | |
| 2024-02-23 | RBC Capital | $100.0000 | Sector Perform | |
| 2024-02-23 | Cantor Fitzgerald | $100.0000 | Overweight | |
| 2024-02-23 | Piper Sandler | $115.00 | $107 | Overweight |
| 2024-01-30 | Baird | $127.00 | $104.0000 | Outperform |
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-01-13 | $65.80 | -2.34% |
| 2025-01-14 | $64.95 | -1.30% |
| 2025-01-15 | $66.17 | 1.88% |
| 2025-01-16 | $65.63 | -0.82% |
| 2025-01-17 | $66.98 | 2.06% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Feb. is $67.34 , for 2026 Jan. is $80.88 , for 2029 Jan. is $115.91 , for 2030 Jan. is $97.67 , for 2034 Jan. is $65.99 , and for 2035 Jan. is $52.99.
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Feb. | $67.34 | -0.06% |
| 2025 Mar. | $66.77 | -0.85% |
| 2025 Apr. | $66.12 | -0.98% |
| 2025 May. | $65.67 | -0.68% |
| 2025 Jun. | $64.92 | -1.14% |
| 2025 Jul. | $63.64 | -1.97% |
| 2025 Aug. | $62.87 | -1.22% |
| 2025 Sep. | $62.91 | 0.08% |
| 2025 Oct. | $64.52 | 2.56% |
| 2025 Nov. | $67.77 | 5.03% |
| 2025 Dec. | $72.65 | 7.20% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $80.88 | 11.34% |
| 2026 Feb. | $88.10 | 8.93% |
| 2026 Mar. | $97.13 | 10.24% |
| 2026 Apr. | $108.23 | 11.43% |
| 2026 May. | $118.90 | 9.85% |
| 2026 Jun. | $127.12 | 6.91% |
| 2026 Jul. | $132.17 | 3.98% |
| 2026 Aug. | $134.41 | 1.70% |
| 2026 Sep. | $135.53 | 0.83% |
| 2026 Oct. | $136.13 | 0.44% |
| 2026 Nov. | $136.63 | 0.37% |
| 2026 Dec. | $137.30 | 0.49% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $138.42 | 0.81% |
| 2027 Feb. | $140.15 | 1.25% |
| 2027 Mar. | $142.20 | 1.46% |
| 2027 Apr. | $144.35 | 1.51% |
| 2027 May. | $146.12 | 1.22% |
| 2027 Jun. | $146.70 | 0.40% |
| 2027 Jul. | $145.83 | -0.60% |
| 2027 Aug. | $143.47 | -1.61% |
| 2027 Sep. | $139.63 | -2.68% |
| 2027 Oct. | $134.16 | -3.92% |
| 2027 Nov. | $126.51 | -5.70% |
| 2027 Dec. | $116.80 | -7.67% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $106.17 | -9.10% |
| 2028 Feb. | $96.72 | -8.90% |
| 2028 Mar. | $91.11 | -5.80% |
| 2028 Apr. | $89.68 | -1.56% |
| 2028 May. | $90.93 | 1.40% |
| 2028 Jun. | $93.83 | 3.19% |
| 2028 Jul. | $97.65 | 4.07% |
| 2028 Aug. | $101.74 | 4.19% |
| 2028 Sep. | $105.90 | 4.09% |
| 2028 Oct. | $109.93 | 3.80% |
| 2028 Nov. | $113.56 | 3.31% |
| 2028 Dec. | $116.09 | 2.23% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $115.91 | -0.15% |
| 2029 Feb. | $111.48 | -3.82% |
| 2029 Mar. | $104.02 | -6.69% |
| 2029 Apr. | $96.61 | -7.12% |
| 2029 May. | $91.08 | -5.73% |
| 2029 Jun. | $87.69 | -3.72% |
| 2029 Jul. | $86.13 | -1.78% |
| 2029 Aug. | $86.06 | -0.09% |
| 2029 Sep. | $87.10 | 1.21% |
| 2029 Oct. | $88.94 | 2.12% |
| 2029 Nov. | $91.40 | 2.76% |
| 2029 Dec. | $94.34 | 3.22% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $97.67 | 3.53% |
| 2030 Feb. | $100.66 | 3.06% |
| 2030 Mar. | $102.11 | 1.44% |
| 2030 Apr. | $101.44 | -0.66% |
| 2030 May. | $98.62 | -2.78% |
| 2030 Jun. | $94.51 | -4.17% |
| 2030 Jul. | $90.15 | -4.61% |
| 2030 Aug. | $86.12 | -4.47% |
| 2030 Sep. | $82.67 | -4.00% |
| 2030 Oct. | $80.05 | -3.17% |
| 2030 Nov. | $78.51 | -1.92% |
| 2030 Dec. | $78.14 | -0.47% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $78.81 | 0.86% |
| 2031 Feb. | $80.33 | 1.92% |
| 2031 Mar. | $82.43 | 2.62% |
| 2031 Apr. | $84.74 | 2.81% |
| 2031 May. | $86.79 | 2.42% |
| 2031 Jun. | $88.14 | 1.55% |
| 2031 Jul. | $88.59 | 0.52% |
| 2031 Aug. | $88.06 | -0.60% |
| 2031 Sep. | $86.53 | -1.73% |
| 2031 Oct. | $84.18 | -2.72% |
| 2031 Nov. | $81.27 | -3.45% |
| 2031 Dec. | $78.16 | -3.83% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $75.17 | -3.82% |
| 2032 Feb. | $72.63 | -3.39% |
| 2032 Mar. | $70.84 | -2.46% |
| 2032 Apr. | $70.02 | -1.15% |
| 2032 May. | $70.18 | 0.23% |
| 2032 Jun. | $71.14 | 1.37% |
| 2032 Jul. | $72.64 | 2.11% |
| 2032 Aug. | $74.32 | 2.31% |
| 2032 Sep. | $75.82 | 2.02% |
| 2032 Oct. | $76.97 | 1.52% |
| 2032 Nov. | $77.66 | 0.89% |
| 2032 Dec. | $77.63 | -0.03% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $76.71 | -1.18% |
| 2033 Feb. | $74.96 | -2.28% |
| 2033 Mar. | $72.62 | -3.13% |
| 2033 Apr. | $69.95 | -3.68% |
| 2033 May. | $67.19 | -3.94% |
| 2033 Jun. | $64.64 | -3.79% |
| 2033 Jul. | $62.64 | -3.10% |
| 2033 Aug. | $61.48 | -1.85% |
| 2033 Sep. | $61.27 | -0.34% |
| 2033 Oct. | $61.89 | 1.00% |
| 2033 Nov. | $63.07 | 1.91% |
| 2033 Dec. | $64.52 | 2.30% |
BMRN : BioMarin Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $65.99 | 2.28% |
| 2034 Feb. | $67.28 | 1.95% |
| 2034 Mar. | $68.15 | 1.29% |
| 2034 Apr. | $68.35 | 0.30% |
| 2034 May. | $67.77 | -0.85% |
| 2034 Jun. | $66.44 | -1.97% |
| 2034 Jul. | $64.50 | -2.91% |
| 2034 Aug. | $62.17 | -3.61% |
| 2034 Sep. | $59.65 | -4.06% |
| 2034 Oct. | $57.15 | -4.19% |
| 2034 Nov. | $54.99 | -3.79% |
| 2034 Dec. | $53.52 | -2.67% |
BMRN : BioMarin Pharmaceutical stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $52.99 | -0.99% |
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2025 Feb. is $67.3405271555131 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2026 Jan. is $80.8824197754664 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2029 Jan. is $115.91391586448 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2030 Jan. is $97.6700858382709 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2034 Jan. is $65.9930561565813 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2035 Jan. is $52.9871165812408
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go UP . Therefore, AIPickup would say that BioMarin Pharmaceutical (BMRN) stock is NOT overvalued.
Will BioMarin Pharmaceutical stock price go up?
Yes. The BioMarin Pharmaceutical stock price forecast for 2026 Jan. is $80.8824197754664
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2025-01-10 is $67.379997253418 and forecast for 2026 Jan. is $80.88, BioMarin Pharmaceutical stock is a good 1 year investment.
14 Days Historical Data for BioMarin Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BMRN stock price for 2024-12-19 | $65.00 | $64.63 | $63.93 | $65.62 |
| BMRN stock price for 2024-12-20 | $65.66 | $64.90 | $64.07 | $66.27 |
| BMRN stock price for 2024-12-23 | $66.27 | $65.07 | $64.65 | $66.46 |
| BMRN stock price for 2024-12-24 | $66.63 | $65.96 | $65.25 | $67.09 |
| BMRN stock price for 2024-12-26 | $67.02 | $66.30 | $66.21 | $67.10 |
| BMRN stock price for 2024-12-27 | $66.89 | $66.89 | $66.38 | $67.47 |
| BMRN stock price for 2024-12-30 | $65.45 | $66.30 | $65.24 | $66.46 |
| BMRN stock price for 2024-12-31 | $65.73 | $65.74 | $65.33 | $66.16 |
| BMRN stock price for 2025-01-02 | $66.49 | $65.97 | $65.86 | $66.74 |
| BMRN stock price for 2025-01-03 | $66.83 | $66.56 | $66.44 | $67.50 |
| BMRN stock price for 2025-01-06 | $67.07 | $66.93 | $66.70 | $67.75 |
| BMRN stock price for 2025-01-07 | $67.90 | $67.07 | $66.91 | $68.85 |
| BMRN stock price for 2025-01-08 | $68.38 | $67.90 | $67.43 | $69.70 |
| BMRN stock price for 2025-01-10 | $67.38 | $67.26 | $66.01 | $67.94 |